Systemic Immune-Inflammation Index and Changes of Neutrophil-Lymphocyte Ratio as Prognostic Biomarkers for Patients With Pancreatic Cancer Treated With Immune Checkpoint Blockade

The efficacy of current treatment regimens for pancreatic cancer (PC) remains unsatisfactory. In recent years, immune checkpoint blockade (ICB) therapy has shown promising anti-tumor outcomes in many malignancies, including PC. Inexpensive and readily available biomarkers which predict therapeutic r...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Jin, Han, Xiao, Zha, Haoran, Tao, Haitao, Li, Xiaoyan, Yuan, Fang, Chen, Guangying, Wang, Lijie, Ma, Junxun, Hu, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943876/
https://www.ncbi.nlm.nih.gov/pubmed/33718140
http://dx.doi.org/10.3389/fonc.2021.585271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943876/
https://www.ncbi.nlm.nih.gov/pubmed/33718140
http://dx.doi.org/10.3389/fonc.2021.585271

Ejemplares similares